Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...
Tobacco stocks gained slightly on Thursday after the FDA has authorized the marketing of 20 Zyn nicotine pouch products ...
Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn ...
Analyst Matthew Smith of Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report), with a price target of ...
We came across a bullish thesis on Philip Morris International Inc. (PM) on Substack by Chit Chat Stocks. In this article, we ...
Matthew Farrelly, Ph.D., director of the Office of Science in the FDA’s Center for Tobacco Products, stated, “In this case, ...
Analyst Lisa Lewandowski from Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report) and keeping the price ...
PM's solid fundamentals and commitment to innovation and cost efficiencies position the company well for sustained growth ...
Fintel reports that on January 16, 2025, Morgan Stanley initiated coverage of Philip Morris International (NYSE:PM) with a ...
The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious ...
Long sensing the way the winds were changing on attitudes to cigarettes, the industry has been pivoting to new products, such ...
Philip Morris International shares edged up slightly after the Food and Drug Administration authorized marketing for 20 Zyn nicotine-pouch products. The stock rose about 1%, to $119.40, late Thursday ...